clinical dermatology

April Clinical Considerations for NP's, PAsIn this month's Clinical Considerations, we look at handling the difficult patient, how to improve our diagnostic skills and the latest psoriasis drug approval.
Isotretinoin still the best drug for acneAs part of its updated guidelines for the treatment of acne published early last year, the American Academy of Dermatology included new recommendations for the use of oral isotretinoin.
Creating the virtual HS multispecialty clinicExpert dermatologist describes how to create the virtual multispecialty clinic to address the complex needs of hidradenitis suppurativa.
Nonablative technologies and the HS patientNonablative lasers, which are essentially modified hair removal lasers, offer treatment benefits for HS patients with stage 1 or stage 2 disease, according to dermatologist.
Melanoma staging updatesThe American Joint Committee on Cancer (AJCC) 8th Edition Melanoma Staging System includes important changes .
New topical hemostatic device in pipelineIf cleared, dermatologists might find the technology useful when excising lesions in patients on blood thinners and more.
Topical agents for acneWhen it comes to choosing topical agents for treating acne, separating fact from fiction can be challenging for dermatologists.
Oral antibiotics for acneDermatologists should turn to oral antibiotics for treating acne when topical medications have failed or are too irritating.
Targeted treatments for atopic dermatitisEmerging treatments are expected to help fill the need for safer and more effective therapies for atopic dermatitis (AD). Both systemic and topical treatments are needed to provide full and complete treatment for patients with AD. Targeting the specific axis or axes that control AD may contribute to developing personalized approaches to treatment
Therapies for hidradenitis suppurativaTNF inhibitors adalimumab and infliximab have evidence-based efficacy for the treatment of hidradentitis suppurativa (HS). Anti-interleukin inhibitors ustekinumab and anakinra also being evaluated in small studies for treatment of HS. Antibiotics, hormones, retinoids, steroids and laser therapies directly targeting the lesions round out an effective treatment plan for HS patients.